Shanghai Junshi Biosciences Co., Ltd. Class H ( (HK:1877) ) has issued an announcement.
Shanghai Junshi Biosciences Co., Ltd. has announced the establishment of a Compliance Committee effective from March 27, 2025. This committee aims to enhance the company’s compliance management system, mitigate compliance risks, and ensure operations align with legal and regulatory standards, thereby supporting the company’s sustainable growth.
More about Shanghai Junshi Biosciences Co., Ltd. Class H
Shanghai Junshi Biosciences Co., Ltd. is a company incorporated in the People’s Republic of China, primarily operating in the biosciences industry. The company focuses on developing and providing innovative pharmaceutical products and solutions.
YTD Price Performance: 20.55%
Average Trading Volume: 1,550,382
Technical Sentiment Signal: Hold
Current Market Cap: HK$26.82B
See more insights into 1877 stock on TipRanks’ Stock Analysis page.